AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017
Oct 31, 2017
29864_dirs_2017-10-31_a322f67f-bfce-4cee-bbf0-c9ecd3482e65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-10-31
Reporting Person: SMITH IAN F (EVP, COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-31 | Common Stock | S | 1700 | $142.40 | Disposed | 114188 | Direct |
| 2017-10-31 | Common Stock | S | 5200 | $143.47 | Disposed | 108988 | Direct |
| 2017-10-31 | Common Stock | S | 32945 | $144.47 | Disposed | 76043 | Direct |
| 2017-10-31 | Common Stock | S | 22464 | $145.26 | Disposed | 53579 | Direct |
| 2017-10-31 | Common Stock | S | 5200 | $146.39 | Disposed | 48379 | Direct |
| 2017-10-31 | Common Stock | S | 3500 | $147.40 | Disposed | 44879 | Direct |
| 2017-10-31 | Common Stock | S | 3791 | $148.26 | Disposed | 41088 | Direct |
| 2017-10-31 | Common Stock | S | 200 | $149.34 | Disposed | 40888 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5306 | Indirect |
Footnotes
F1: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.75).
F3: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4: Open market sales reported on this line occurred at a weighted average price of $143.47 (range $142.91 to $143.85).
F5: Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.91 to $144.89).
F6: Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).
F7: Open market sales reported on this line occurred at a weighted average price of $146.39 (range $145.30 to $146.92).
F8: Open market sales reported on this line occurred at a weighted average price of $147.40 (range $146.93 to $147.90).
F9: Open market sales reported on this line occurred at a weighted average price of $148.26 (range $147.93 to $148.70).